trending Market Intelligence /marketintelligence/en/news-insights/trending/01Vhrr1RxJpceBZ7wFYG0A2 content esgSubNav
In This List

Cerulean's chief medical officer, chief scientific officer set for exit

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Cerulean's chief medical officer, chief scientific officer set for exit

Cerulean Pharma Inc. and Adrian Senderowicz, senior vice president and chief medical officer, agreed that Senderowicz's employment with the company will end June 15.

In addition, the company and Scott Eliasof, senior vice president and chief scientific officer, agreed that Eliasof's employment with Cerulean will end June 30.

Senderowicz and Eliasof's decisions to terminate their employment did not involve any disagreements with the company, its management or the board.